158 related articles for article (PubMed ID: 37771000)
41. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukaemia.
Koike K; Matsuda K
Br J Haematol; 2008 May; 141(5):567-75. PubMed ID: 18422786
[TBL] [Abstract][Full Text] [Related]
42. Juvenile myelomonocytic leukemia with PTPN11 mutation in a 23-month-old girl.
Jakovljević G; Kardum-Skelin I; Rogosić S; Nakić M
Coll Antropol; 2010 Mar; 34(1):251-4. PubMed ID: 20432758
[TBL] [Abstract][Full Text] [Related]
43. Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.
Dvorak CC; Satwani P; Stieglitz E; Cairo MS; Dang H; Pei Q; Gao Y; Wall D; Mazor T; Olshen AB; Parker JS; Kahwash S; Hirsch B; Raimondi S; Patel N; Skeens M; Cooper T; Mehta PA; Grupp SA; Loh ML
Pediatr Blood Cancer; 2018 Jul; 65(7):e27034. PubMed ID: 29528181
[TBL] [Abstract][Full Text] [Related]
44. Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia.
Loh ML
Hematology Am Soc Hematol Educ Program; 2010; 2010():357-62. PubMed ID: 21239819
[TBL] [Abstract][Full Text] [Related]
45. Allogeneic hematopoietic cell transplantation in patients with juvenile myelomonocytic leukemia in Korea: a report of the Korean Pediatric Hematology-Oncology Group.
Yi ES; Kim SK; Ju HY; Lee JW; Cho B; Kim BK; Kang HJ; Baek HJ; Kook H; Yang EJ; Lim YT; Ahn WK; Hahn SM; Park SK; Yoo ES; Yoo KH
Bone Marrow Transplant; 2023 Jan; 58(1):20-29. PubMed ID: 36167906
[TBL] [Abstract][Full Text] [Related]
46. Significance of WT1 and multiparameter flow cytometry assessment in patients with chronic myelomonocytic leukemia receiving allogeneic hematopoietic stem cell transplantation.
Pan X; Gao M; Sun Y; Zhou Y; Wang K; Wang Y; Xu L; Zhang X; Huang X; Zhao XS
Int J Lab Hematol; 2022 Jun; 44(3):510-517. PubMed ID: 35061336
[TBL] [Abstract][Full Text] [Related]
47. Juvenile Myelomonocytic Leukemia in Turkey: A Retrospective Analysis of Sixty-five Patients.
Tüfekçi Ö; Koçak Ü; Kaya Z; Yenicesu İ; Albayrak C; Albayrak D; Yılmaz Bengoa Ş; Patıroğlu T; Karakükçü M; Ünal E; Ünal İnce E; İleri T; Ertem M; Celkan T; Özdemir GN; Sarper N; Kaçar D; Yaralı N; Özbek NY; Küpesiz A; Karapınar T; Vergin C; Çalışkan Ü; Tokgöz H; Sezgin Evim M; Baytan B; Güneş AM; Yılmaz Karapınar D; Karaman S; Uygun V; Karasu G; Yeşilipek MA; Koç A; Erduran E; Atabay B; Öniz H; Ören H
Turk J Haematol; 2018 Mar; 35(1):27-34. PubMed ID: 28179213
[TBL] [Abstract][Full Text] [Related]
48. How I treat juvenile myelomonocytic leukemia.
Locatelli F; Niemeyer CM
Blood; 2015 Feb; 125(7):1083-90. PubMed ID: 25564399
[TBL] [Abstract][Full Text] [Related]
49. A child with juvenile myelomonocytic leukemia possessing a concurrent germline CBL mutation and a NF1 variant of uncertain significance: A rare case with a common problem in the era of high-throughput sequencing.
Wang WH; Lu MY; Tsai CH; Wang SC; Chou SW; Jou ST
J Formos Med Assoc; 2021 Apr; 120(4):1148-1152. PubMed ID: 32933826
[TBL] [Abstract][Full Text] [Related]
50. Current management of juvenile myelomonocytic leukemia and the impact of RAS mutations.
Yoshida N; Doisaki S; Kojima S
Paediatr Drugs; 2012 Jun; 14(3):157-63. PubMed ID: 22480363
[TBL] [Abstract][Full Text] [Related]
51. Hemophagocytic Lymphohistiocytosis Secondary to Juvenile Myelomonocytic Leukemia: A Case Report and Review of the Literature.
Zheng F; Jia Y; Zhang L; Qin J
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e580-e584. PubMed ID: 34862352
[TBL] [Abstract][Full Text] [Related]
52. Juvenile myelomonocytic leukemia: who's the driver at the wheel?
Niemeyer CM; Flotho C
Blood; 2019 Mar; 133(10):1060-1070. PubMed ID: 30670449
[TBL] [Abstract][Full Text] [Related]
53. Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study.
Park JB; Han SJ; Lee SB; Kim DH; Cheon JH; Hwang SW; Ye BD; Yang SK; Park SJ; Park SH;
Yonsei Med J; 2024 May; 65(5):265-275. PubMed ID: 38653565
[TBL] [Abstract][Full Text] [Related]
54. Management of Two Juvenile Myelomonocytic Leukemia Patients According to Clinical and Genetic Features.
Tüfekçi Ö; Ören H; Demir Yenigürbüz F; Gözmen S; Karapınar TH; İrken G
Turk J Haematol; 2015 Jun; 32(2):175-9. PubMed ID: 26316488
[TBL] [Abstract][Full Text] [Related]
55. Resolution of Behcet's disease after non-myeloablative allogeneic stem cell transplant for acute myeloid leukaemia.
Lim SH; Hulsey M; Esler WV
Rheumatology (Oxford); 2009 Jan; 48(1):88-9. PubMed ID: 18987011
[No Abstract] [Full Text] [Related]
56. Clinical outcome of cord blood transplantation for nine children with juvenile myelomonocytic leukemia receiving fludarabine-busulfan-cyclophosphamide-based conditioning.
Li G; Sun Z; Geng L; Wan X; Zhu X; Tang B; Tong J; Yao W; Song K; Qiang P; Zhang L; Zhang X; Zhang S; Liu H
Pediatr Transplant; 2022 Mar; 26(2):e14181. PubMed ID: 34747111
[TBL] [Abstract][Full Text] [Related]
57. Autologous Hematopoietic Stem Cell Transplantation for Behçet's Disease: A Retrospective Survey of Patients Treated in Europe, on Behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Puyade M; Patel A; Lim YJ; Blank N; Badoglio M; Gualandi F; Ma DD; Maximova N; Greco R; Alexander T; Snowden JA
Front Immunol; 2021; 12():638709. PubMed ID: 34025648
[TBL] [Abstract][Full Text] [Related]
58. Outcomes of immunological interventions for mixed chimerism following allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia.
Inagaki J; Fukano R; Nishikawa T; Nakashima K; Sawa D; Ito N; Okamura J
Pediatr Blood Cancer; 2013 Jan; 60(1):116-20. PubMed ID: 22847790
[TBL] [Abstract][Full Text] [Related]
59. Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia.
Raygada M; Arthur DC; Wayne AS; Rennert OM; Toretsky JA; Stratakis CA
Pediatr Blood Cancer; 2010 Jan; 54(1):173-5. PubMed ID: 19785027
[TBL] [Abstract][Full Text] [Related]
60. Second allogeneic hematopoietic stem cell transplantation for juvenile myelomonocytic leukemia: case report and literature review.
Chang YH; Jou ST; Lin DT; Lu MY; Lin KH
J Pediatr Hematol Oncol; 2004 Mar; 26(3):190-3. PubMed ID: 15125612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
